Loading...

Joseph Rabban, III, MD, MPH

TitleProfessor
SchoolUCSF School of Medicine
DepartmentPathology
Address1825 4th Street
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Brown UniversitySc.B.1992
    Harvard UniversityM.D.1998School of Medicine
    Harvard UniversityM.P.H.1998School of Public Health

    Collapse Overview 
    Collapse Overview
    I am a diagnostic surgical pathologist with a focus on women's cancer, including gynecologic cancers (ovary, uterus, cervix, fallopian tubes, peritoneum, vagina, vulva) and breast cancers. I provide diagnostic services to the clinics and operating rooms at Moffitt Hospital and Mt Zion Cancer Center and collaborate clinically with colleagues in the Gynecologic Oncology division and Breast Care Center.

    My clinical research focuses on improving predictive and prognostic understanding of gynecologic and breast cancers using pathologic variables, as well as improving pathologic differential diagnosis. Currently my investigations are centered on pathology of inherited ovarian and fallopian tube cancers.

    I enjoy collaborative investigations not only with clinical colleagues but also with basic scientists and currently provide diagnostic services for a variety of scientists at UCSF in the area of women's cancers.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Barragan F, Irwin JC, Balayan S, Erikson DW, Chen JC, Houshdaran S, Piltonen TT, Spitzer TL, George A, Rabban JT, Nezhat C, Giudice LC. Human Endometrial Fibroblasts Derived from Mesenchymal Progenitors Inherit Progesterone Resistance and Acquire an Inflammatory Phenotype in the Endometrial Niche in Endometriosis. Biol Reprod. 2016 May; 94(5):118. PMID: 27075616.
      View in: PubMed
    2. Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Am J Surg Pathol. 2016 Mar; 40(3):419-32. PMID: 26551622.
      View in: PubMed
    3. Winkelman WD, Rabban JT, Korn AP. Vaginal Calculus in a Woman With Mixed Urinary Incontinence and Vaginal Mesh Exposure. Female Pelvic Med Reconstr Surg. 2016 Mar-Apr; 22(2):e20-1. PMID: 26825410.
      View in: PubMed
    4. Odisho AY, Rabban JT, Meng MV. Development of CNS-type Primitive Neuroectodermal Tumor in Metastatic Testicular Mixed Germ Cell Tumor. Urol Case Rep. 2016 May; 6:7-8. PMID: 27169016.
      View in: PubMed
    5. Karnezis AN, Wang Y, Ramos P, Hendricks WP, Oliva E, D'Angelo E, Prat J, Nucci MR, Nielsen TO, Chow C, Leung S, Kommoss F, Kommoss S, Silva A, Ronnett BM, Rabban JT, Bowtell DD, Weissman BE, Trent JM, Gilks CB, Huntsman DG. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type. J Pathol. 2016 Feb; 238(3):389-400. PMID: 26356327.
      View in: PubMed
    6. Joseph NM, Solomon DA, Frizzell N, Rabban JT, Zaloudek C, Garg K. Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients. Am J Surg Pathol. 2015 Nov; 39(11):1529-39. PMID: 26457356.
      View in: PubMed
    7. Rabban JT, Firetag B, Sangoi AR, Post MD, Zaloudek CJ. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex. Am J Surg Pathol. 2015 Aug; 39(8):1015-25. PMID: 25786086.
      View in: PubMed
    8. Rabban JT, Vohra P, Zaloudek CJ. Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia. Am J Surg Pathol. 2015 Jan; 39(1):35-51. PMID: 25025442.
      View in: PubMed
    9. Tamaresis JS, Irwin JC, Goldfien GA, Rabban JT, Burney RO, Nezhat C, DePaolo LV, Giudice LC. Molecular classification of endometriosis and disease stage using high-dimensional genomic data. Endocrinology. 2014 Dec; 155(12):4986-99. PMID: 25243856; PMCID: PMC4239429.
    10. Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Am J Surg Pathol. 2014 Jun; 38(6):793-800. PMID: 24503759.
      View in: PubMed
    11. Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek CJ. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery. Am J Surg Pathol. 2014 Jun; 38(6):729-42. PMID: 24820399.
      View in: PubMed
    12. Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology. 2013 Jan; 62(1):71-88. PMID: 23240671.
      View in: PubMed
    13. Karnezis AN, Aysal A, Zaloudek CJ, Rabban JT. Transitional cell-like morphology in ovarian endometrioid carcinoma: morphologic, immunohistochemical, and behavioral features distinguishing it from high-grade serous carcinoma. Am J Surg Pathol. 2013 Jan; 37(1):24-37. PMID: 23108017.
      View in: PubMed
    14. Fadare O, Parkash V, Dupont WD, Acs G, Atkins KA, Irving JA, Pirog EC, Quade BJ, Quddus MR, Rabban JT, Vang R, Hecht JL. The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features. Am J Surg Pathol. 2012 Aug; 36(8):1107-18. PMID: 22790851.
      View in: PubMed
    15. Aysal A, Karnezis A, Medhi I, Grenert JP, Zaloudek CJ, Rabban JT. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Am J Surg Pathol. 2012 Feb; 36(2):163-72. PMID: 22189970.
      View in: PubMed
    16. Powell CB, Chen LM, McLennan J, Crawford B, Zaloudek C, Rabban JT, Moore DH, Ziegler J. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer. 2011 Jul; 21(5):846-51. PMID: 21670699.
      View in: PubMed
    17. Rabban JT, Mackey A, Powell CB, Crawford B, Zaloudek CJ, Chen LM. Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation. Gynecol Oncol. 2011 Jun 1; 121(3):466-71. PMID: 21353295.
      View in: PubMed
    18. Rabban JT, Karnezis AN, Zaloudek CJ. Junctional epithelial zones of the fallopian tube: cancer hotspots? Int J Gynecol Pathol. 2011 Jan; 30(1):1-3. PMID: 21131841.
      View in: PubMed
    19. Rabban JT, McAlhany S, Lerwill MF, Grenert JP, Zaloudek CJ. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Am J Surg Pathol. 2010 Feb; 34(2):137-46. PMID: 20061933.
      View in: PubMed
    20. Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol. 2009 Dec; 33(12):1878-85. PMID: 19898224.
      View in: PubMed
    21. Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol. 2009 Aug; 33(8):1125-36. PMID: 19440148.
      View in: PubMed
    22. Rabban JT, Glidden D, Kwan ML, Chen YY. Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease. Am J Surg Pathol. 2009 Feb; 33(2):256-63. PMID: 18936689.
      View in: PubMed
    23. Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek CJ. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Int J Gynecol Pathol. 2009 Jan; 28(1):41-8. PMID: 19047909.
      View in: PubMed
    24. Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations. Am J Surg Pathol. 2009 Jan; 33(1):111-9. PMID: 18830124.
      View in: PubMed
    25. Hosfield EM, Rabban JT, Chen LM, Zaloudek CJ. Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysis. Int J Gynecol Pathol. 2008 Oct; 27(4):465-74. PMID: 18753977.
      View in: PubMed
    26. Rabban JT, Chen YY. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma. Hum Pathol. 2008 Feb; 39(2):175-83. PMID: 18206495.
      View in: PubMed
    27. Rabban JT, Zaloudek CJ. Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis. Pathology. 2007 Feb; 39(1):125-33. PMID: 17365828.
      View in: PubMed
    28. Rabban JT, Gupta D, Zaloudek CJ, Chen LM. Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: a rare association of a high-risk endometrial cancer with anestrogenic ovarian tumor. Gynecol Oncol. 2006 Dec; 103(3):1164-8. PMID: 17034837.
      View in: PubMed
    29. Rabban JT, Dal Cin P, Oliva E. HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma. Int J Gynecol Pathol. 2006 Oct; 25(4):403-7. PMID: 16990720.
      View in: PubMed
    30. Rabban JT, Swain RS, Zaloudek CJ, Chase DR, Chen YY. Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers. Mod Pathol. 2006 Oct; 19(10):1351-7. PMID: 16810311.
      View in: PubMed
    31. Rabban JT, Koerner FC, Lerwill MF. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Hum Pathol. 2006 Jul; 37(7):787-93. PMID: 16784976.
      View in: PubMed
    32. Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol. 2005 Oct; 29(10):1348-55. PMID: 16160478.
      View in: PubMed
    33. Rabban JT, Bell DA. Current issues in the pathology of ovarian cancer. J Reprod Med. 2005 Jun; 50(6):467-74. PMID: 16050571.
      View in: PubMed
    34. Jones JL, Rhei E, Gadd MA, Howard-Mcnatt M, Hughes KS, Lesnikoski BA, Christian RL, Rabban JT, Kaelin C, Smith BL. Predictive value of sentinel lymph node biopsy prior to neoadjuvant chemotherapy in clinically node negative breast cancer. J Clin Oncol. 2004 Jul 15; 22(14_suppl):606. PMID: 28016633.
      View in: PubMed
    35. Rabban JT, Sgroi DC. Sclerosing lesions of the breast. Semin Diagn Pathol. 2004 Feb; 21(1):42-7. PMID: 15074558.
      View in: PubMed
    Joseph's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP